Medicare Enrolled
Dr. Pavan Yerramsetty, M.D.
Neurology · Raleigh, NC
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Yerramsetty from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Yerramsetty?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Yerramsetty
Dr. Pavan Yerramsetty is a neurology specialist in Raleigh, NC, with 20 years of NPI registration. Based on federal Medicare data, Dr. Yerramsetty performed 25,598 Medicare services across 1,309 unique beneficiaries.
Between the years covered by Open Payments, Dr. Yerramsetty received a total of $7,983 from 62 pharmaceutical and/or device companies across 570 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Yerramsetty is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 3% volume in NC
$7,983 industry payments
Medicare Practice Summary
Medicare Utilization ↗25,598
Medicare services
Top 3% in NC for neurology
1,309
Unique beneficiaries
$20
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,280 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Injection, natalizumab, 1 mg | 12,000 | $19 | $35 |
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
6,710 | $4 | $13 |
| Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | 3,150 | $38 | $90 |
| MRI contrast dye injection (gadobutrol) | 1,600 | $0 | $2 |
| Betamethasone steroid injection An injection containing a combination of betamethasone acetate and betamethasone sodium phosphate. |
620 | $5 | $15 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
210 | $84 | $220 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
166 | $117 | $380 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
88 | $220 | $1,252 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
79 | $4 | $15 |
| Injection of anesthetic agent and/or steroid into other nerve or branch | 71 | $47 | $469 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
70 | $46 | $228 |
| Injection, methylprednisolone acetate, 40 mg | 60 | $5 | $15 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
56 | $112 | $300 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
52 | $11 | $100 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
49 | $16 | $166 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
47 | $46 | $239 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
46 | $93 | $510 |
| Trigger point injection, 3 or more muscles Injection of medication into three or more specific muscle trigger points to relieve pain. |
39 | $44 | $195 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the upper or middle spine while using imaging guidance to ensure accurate placement. |
38 | $185 | $939 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
35 | $172 | $939 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
35 | $45 | $600 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
35 | $67 | $150 |
| Facet joint injection, second level, with imaging An injection into a second spinal facet joint in the upper or middle spine, guided by imaging to ensure accurate placement. |
34 | $96 | $766 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
34 | $89 | $579 |
| Bilateral facial and neck nerve muscle paralysis injection Injection of a chemical agent to paralyze muscles in the face and neck on both sides. |
31 | $107 | $560 |
| Additional sacral spine nerve root injection with imaging An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging. |
30 | $85 | $665 |
| Injection of anesthetic or steroid into sacroiliac joint with imaging guidance This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection. |
29 | $145 | $473 |
| Fluoroscopic guidance for needle placement Use of real-time X-ray imaging to guide the precise placement of a needle during a medical procedure. |
26 | $82 | $400 |
| Spinal injection with imaging guidance A procedure where medication is injected into the middle or upper part of the spinal canal. Imaging technology is used to guide the needle to the correct location. |
25 | $194 | $1,578 |
| MRI scan of brain, without contrast A magnetic resonance imaging test of the brain that does not use contrast dye. This procedure creates detailed images of the brain's structure using magnetic fields and radio waves. |
24 | $95 | $1,980 |
| MRI of upper spine without contrast An MRI scan of the upper spinal canal that does not use contrast dye. This imaging test uses magnetic fields and radio waves to create detailed pictures of the spine. |
23 | $68 | $1,518 |
| MRI of lower spine, without contrast A magnetic resonance imaging scan of the lower spinal canal that does not use contrast dye to create detailed images of the spine. |
23 | $90 | $1,574 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
15 | $21 | $166 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
13 | $86 | $266 |
| Lumbar puncture with imaging guidance A procedure to remove spinal fluid from the lower back for diagnostic testing, performed using imaging guidance. |
12 | $162 | $1,400 |
| Facet joint nerve destruction, single joint This procedure uses imaging guidance to destroy the nerves supplying a single upper or middle spinal facet joint. It is performed to interrupt pain signals from that specific joint. |
12 | $389 | $2,038 |
| Facet joint nerve destruction, single joint A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals. |
11 | $422 | $2,000 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.6% high complexity
97.3% medium
2.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$7,983
Total received (2018-2024)
Avg $1,140/year across 7 years
Top 24% in NC for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
62
Companies
570
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,983 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,244
2023
$2,065
2022
$704
2021
$123
2020
$365
2019
$1,150
2018
$1,332
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$431
Averitas Pharma Inc.
$381
Lundbeck LLC
$294
Teva Pharmaceuticals USA, Inc.
$158
Neurocrine Biosciences, Inc.
$154
Lilly USA, LLC
$141
Collegium Pharmaceutical, Inc.
$135
BIOTRONIK NRO, Inc.
$107
Alexion Pharmaceuticals, Inc.
$102
PFIZER INC.
$88
Biogen, Inc.
$57
ARGENX US, INC.
$51
Neurelis, Inc.
$47
UCB, Inc.
$43
GENZYME CORPORATION
$21
Siemens Medical Solutions USA, Inc.
$19
Eisai Inc.
$15
Top 3 companies account for 49.3% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$588
AbbVie Inc.
$587
Collegium Pharmaceutical, Inc.
$577
Averitas Pharma Inc.
$526
Lundbeck LLC
$399
Forte Bio-Pharma LLC
$368
Teva Pharmaceuticals USA, Inc.
$318
Lilly USA, LLC
$309
PFIZER INC.
$270
Alexion Pharmaceuticals, Inc.
$269
Supernus Pharmaceuticals, Inc.
$255
Amgen Inc.
$252
Neurocrine Biosciences, Inc.
$228
BOSTON SCIENTIFIC CORPORATION
$207
Zyla Life Sciences
$154
Daiichi Sankyo Inc.
$148
ASSERTIO THERAPEUTICS, Inc.
$134
SK Life Science, Inc.
$132
IMPEL PHARMACEUTICALS INC.
$132
Novartis Pharmaceuticals Corporation
$119
Pernix Therapeutics Holdings, Inc.
$117
Biogen, Inc.
$108
ARGENX US, INC.
$107
BIOTRONIK NRO, Inc.
$107
UCB, Inc.
$104
Neurelis, Inc.
$102
Allergan Inc.
$91
Amneal Pharmaceuticals LLC
$87
GENZYME CORPORATION
$87
Assertio Therapeutics, Inc.
$86
Scilex Pharmaceuticals Inc.
$82
Allergan, Inc.
$80
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$74
ARBOR PHARMACEUTICALS, INC.
$68
GRT US Holding, Inc.
$63
Kowa Pharmaceuticals America, Inc.
$63
Azurity Pharmaceuticals, Inc.
$51
Upsher-Smith Laboratories LLC
$42
Kaleo, Inc.
$42
EMD Serono, Inc.
$39
Bausch Health US, LLC
$36
Takeda Pharmaceuticals U.S.A., Inc.
$33
Saluda Medical Americas, Inc.
$25
GE HealthCare
$25
BioDelivery Sciences International, Inc.
$23
SI-BONE, Inc.
$20
Ferring Pharmaceuticals Inc.
$19
Siemens Medical Solutions USA, Inc.
$19
Grifols USA, LLC
$18
TG THERAPEUTICS, INC.
$18
Octapharma USA, Inc.
$18
Avanir Pharmaceuticals, Inc.
$17
Acorda Therapeutics, Inc
$17
Nevro Corp.
$16
Eisai Inc.
$15
AstraZeneca Pharmaceuticals LP
$15
Medtronic USA, Inc.
$14
Sunovion Pharmaceuticals Inc.
$13
Bayer HealthCare Pharmaceuticals Inc.
$13
Egalet US Inc
$12
Boston Scientific Corporation
$12
GE HEALTHCARE
$12
Top 3 companies account for 21.9% of all-time payments
Associated products mentioned in payments ›
AIMOVIG · AJOVY · AMYVID · APTIOM · AUBAGIO · AUSTEDO · Aimovig · Amitiza · Austedo XR · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · BUNAVAIL 2.1 mg 30-count box · Belbuca · Betaseron · Biograph Vision 600 (8 Ring/64 CT) · Briviact · COMIRNATY · Cambia · Cenobamate · ELYXYB - celecoxib · EMGALITY · EUFLEXXA · EVUSHELD · Evoke SCS · Evzio · FABRAZYME · GENERAL THERAPIES · GRALISE · Gamunex-C · General - Pain Management · Gralise · Horizant · INBRIJA · INGREZZA · LEMTRADA · LIORESAL · LYRICA · LYVISPAH · Leqembi · MIGRANAL · Morphabond ER · NURTEC ODT · Nalocet · Nuedexta · OXAYDO · OXTELLAR XR · Ongentys · PANZYGA · PAXLOVID · Prospera · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUTENZA · Qutenza · RELISTOR · Rebif · Rystiggo · SOLIRIS · SPECTRA WAVEWRITER · SPRIX · Seglentis · Senza Spinal Cord Stimulation System · Soliris · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trintellix · Trudhesa · UBRELVY · ULTOMIRIS · VALTOCO · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · XTAMPZA · ZOHYDRO ER · ZORVOLEX · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zipsor · iFuse Implant
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
115
Per 100K population
10.0
County median income
$101,763
Nearest hospital
REX HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Yerramsetty is a mixed practice specialist, with above-average Medicare volume (top 3% in NC), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Yerramsetty experienced with injection, natalizumab, 1 mg?
Based on Medicare claims data, Dr. Yerramsetty performed 12,000 injection, natalizumab, 1 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Yerramsetty receive payments from pharmaceutical companies?
Yes. Dr. Yerramsetty received a total of $7,983 from 62 companies across 570 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Yerramsetty's costs compare to other neurologists in Raleigh?
Dr. Yerramsetty's average Medicare payment per service is $20. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Yerramsetty) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Raleigh
Browse neurologists in Raleigh ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in NC
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in NC
Which NC neurologists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
By company
Collegium Pharmaceutical, Inc. Payments to Doctors
See all physicians who received payments from Collegium Pharmaceutical, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology